Leukemia - Acute Lymphocytic - ALL: Statistics

Approved by the Cancer.Net Editorial Board, 11/2014

ON THIS PAGE: You will find information about how many people learn they have this type of leukemia each year and some general survival information. Remember, survival rates depend on several factors. To see other pages, use the menu on the side of the screen.

This year, an estimated 6,020 people of all ages (3,140 men and boys and 2,880 women and girls) in the United States will be diagnosed with ALL. About one-third of these will be adults. ALL is much more common in children, especially those younger than 5. An estimated 1,440 deaths (810 men and boys and 630 women and girls) will occur this year; about four out of five of these deaths will be among adults.

Advances in treatment have dramatically lengthened the lives of people with ALL. The five-year survival rate is the percentage of people who survive at least five years after the cancer is detected, excluding those who die from other diseases. The five-year survival rate of people of all ages with ALL increased from 41% for those diagnosed from 1975-1977 to 69% for those diagnosed from 2003 to 2009. It is important to note that how long a person with ALL lives depends on several factors, including biologic features of the disease and a person’s age.

Cancer survival statistics should be interpreted with caution. These estimates are based on data from thousands of people with this type of cancer in the United States each year, but the actual risk for a particular individual may differ. It is not possible to tell a person how long he or she will live with ALL. Because the survival statistics are measured in five-year intervals, they may not represent more recent advances made in the treatment or diagnosis of this cancer. Learn more about understanding statistics.

Statistics adapted from the American Cancer Society’s publication, Cancer Facts & Figures 2014 and the ACS website.

To continue reading this guide, use the menu on the side of your screen to select another section.